Chris Mason

Chris Mason is a highly experienced clinician-scientist and entrepreneur in the field of cell and gene therapy. Here are some key details about him:

Professional Background

Chris Mason has over 30 years of experience in cell and gene therapy, spanning various aspects including:

• Research and development
• Clinical medicine
• Manufacturing
• Commercialization1

Current Roles

• Director on the Board of Directors at Papillon Therapeutics14
• Full Professor of Cell and Gene Therapy at University College London1
• Senior Editor of the journals 'Cell and Gene Therapy Insights' and 'Regenerative Medicine'1

Entrepreneurial Experience

Chris Mason is a serial entrepreneur with several notable positions:

• Founder and CEO of Sun Vectors1
• Co-founder and Non-Executive Director of OriBiotech12
• Founder and former Chief Scientific Officer at Avrobio (NASDAQ: AVRO)12

Industry Involvement

• Instrumental in founding the Alliance for Regenerative Medicine (ARM), where he currently serves as a Board Director1
• Board Director for several companies, including Krystal Biotech1

Qualifications

Chris Mason holds the following qualifications:

• MD (Medical Doctor)
• PhD
• FRCS (Fellow of the Royal College of Surgeons)
• FMedSci (Fellow of the Academy of Medical Sciences)23

His LinkedIn username is profchrismason, as mentioned in the query.